Janssen makes Denmark a core country for clinical trials

US-based Janssen is pleased with the Danish health authorities, the qualifications of Danish doctors and researchers as well as the initiative Trial Nation – so pleased that the company has made Denmark one of its core countries for clinical trials, which means that the firm will increase its clinical activities in future.

Photo: Janssen / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles